肝脏 ›› 2025, Vol. 30 ›› Issue (10): 1402-1405.

• 肝功能衰竭 • 上一篇    下一篇

人工肝治疗慢加急性肝衰竭患者一体化管理模式研究

汪文洋, 胡玲, 童姝睿, 陆雅, 范晔, 徐静, 郝坤艳, 于乐成, 王芳   

  1. 210002 南京 南京大学医学院附属金陵医院(东部战区总医院)感染肝病科(汪文洋,胡玲,童姝睿,陆雅,范晔,徐静,郝坤艳,于乐成),秦淮院区护理部(王芳)
  • 收稿日期:2025-07-20 出版日期:2025-10-31 发布日期:2025-12-16
  • 通讯作者: 王芳,Email: 6764069@qq.com

Research on the integrated management model of artificial liver therapy for patients with acute-on-chronic liver failure

WANG Wen-yang1, HU Ling1, TONG Shu-rui1, LU Ya1, FAN Ye1, XU Jing1, HAO Kun-yan1, YU Yue-cheng1, WANG Fang2   

  1. 1. Center of Hepatology and Department of Infectious Diseases, Jinling Hospital Affiliated to Medical School of Nanjing University (General Hospital of the Eastern Theater Command), Nanjing 210002, China;
    2. Nursing Department of Qinhuai Campus, Jinling Hospital Affiliated to Medical School of Nanjing University (General Hospital of the Eastern Theater Command), Nanjing 210002, China
  • Received:2025-07-20 Online:2025-10-31 Published:2025-12-16
  • Contact: WANG Fang , Email: 6764069@qq.com

摘要: 目的 评估医护一体化管理新模式(MM-IMN)的临床应用效果,为优化人工肝治疗的管理模式提供依据。方法 以2022年1月至2024年12月南京大学医学院附属金陵医院(东部战区总医院)接受人工肝治疗的92例ACLF患者为研究对象,随机分为基于护理为主的传统管理模式组(MM-N组或对照组)和基于医护一体化管理的新模式组(MM-IMN或干预组),每组46例。比较两组患者对人工肝治疗的情感体验(焦虑度、接受度、依从度、满意度)和不良反应发生情况。结果 干预组的高级别焦虑度(3级和4级分别为6.5%和0.0%)占比显著低于对照组(3级和4级分别为19.6%和4.3%),而高接受度占比(分别为82.6%和56.5%)、高依从度占比(分别为80.4%和63.0%)和高满意度占比(分别为56.5%和32.6%)均高于对照组,差异有统计学意义(P<0.05)。干预组在医护共同沟通效果、治疗方案解释清晰、不良反应发现及时和处置得当等维度的满意度得分更高。不良反应发生率在两组间差异无统计学意义,但干预组有低于对照组的趋势(4.3%比13.0%,P=0.267)。结论 人工肝治疗的MM-IMN显著优于传统管理模式,能够更有效地改善ACLF患者的焦虑度,提高其接受度、依从度和满意度,有助于更好地防治人工肝治疗相关不良反应,值得临床推广应用。

关键词: 慢加急性肝衰竭, 人工肝, 医护一体化管理模式, 传统管理模式

Abstract: Objective To evaluate the clinical effect of the new model of management model based on integration of medical and nursing (MM-IMN), and provide a basis for optimizing the management model of artificial liver treatment for patients with acute-on-chronic liver failure (ACLF). Methods Ninety-two patients with ACLF who received artificial liver treatment at Jinling Hospital Affiliated to Medical School of Nanjing University (General Hospital of the Eastern Theater Command), during the period from January 2022 to December 2024 were enrolled. The patients were randomly divided into the control group receiving traditional management model based mainly on nursing (MM-N group) and the intervention group receiving new management model based on integration of medical and nursing (MM-IMN group), with each group consisted of forty-six cases. The emotional experiences (anxiety, acceptance, compliance and satisfaction) and adverse reaction occurrence of the two groups were comparatively analyzed. Results The proportion of patients with higher levels of anxiety in the MM-IMN group (3rd and 4th levels accounting for 6.5% and 0.0% respectively) was significantly lower than that in the MM-N group (3rd and 4th levels accounting for 19.6% and 4.3% respectively), while the proportions of higher acceptance (82.6% and 56.5% respectively), higher compliance (80.4% and 63.0% respectively), and higher satisfaction (56.5% and 32.6% respectively) were all better than those of the MM-N group, all had a significant difference (P<0.05). The MM-IMN group achieved higher satisfaction scores in terms of the effectiveness of joint communication between medical/nursing staff and patients, clear explanation of treatment plans, timely detection and appropriate handling of adverse reactions. There was no significant difference in the incidence of adverse reactions between the two groups; however, a tendency was seen for the MM-IMN group to have a lower rate of adverse reactions than the MM-B group (4.3% vs. 13.0%, P=0.267). Conclusion The new management model based on integration of medical and nursing for artificial liver treatment is significantly superior to the traditional management model. It can more effectively alleviate the anxiety of patients with ACLF, enhance their acceptance, compliance and satisfaction, and help better prevent and treat adverse reactions related to artificial liver treatment. It is worthy of promotion and application.

Key words: Acute-on-chronic liver failure, Artificial liver treatment, Management model based on integration of medical and nursing, Traditional management model